
BTAI vs GSK
$BTAI vs $GSK head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
BTAI vs GSK: the quick read
- ·GSK is the larger company by market cap ($102.41B vs $2M).
- ·GSK has been more active on our scanner (65 vs 0 alerts in 30 days).
- ·BTAI has the smaller float (30.5M vs 2.00B), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·Only one of them shows up on our scanner: GSK triggered 65 unusual-volume alerts in the last 30 days and the other triggered none.
- ·They are not really peers by size: GSK is more than 44267x the market cap of BTAI, so the same dollar of news moves BTAI far harder.
- ·GSK pays a dividend and BTAI does not, which usually means one is being held for income and the other for the move.
- ·They are pulling apart today: GSK is outperforming the other by roughly 98.6 percentage points on the session.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing BTAI and GSK on TheDesperateTrader.
- Is BTAI or GSK the better stock?
- "Better" depends on your goal, and these two are not alike. GSK is the larger company by market cap ($102.41B vs $2M). GSK has been more active on our scanner (65 vs 0 alerts in 30 days). BTAI has the smaller float (30.5M vs 2.00B), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between BTAI and GSK?
- The differences that matter: GSK is roughly 44267x the size of the other by market cap ($2M vs $102.41B); BTAI sits at -3% of its 52-week range against 37% for GSK; only GSK pays a dividend; our scanner flagged BTAI 0 times in the last 30 days against 65 for GSK. Everything above is measured from the latest completed session and SEC filings.
- Which of BTAI and GSK is more active right now?
- Neither is showing unusual volume on the latest session, so nothing here is being driven by a volume spike. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading BTAI or GSK? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.